Constitution Capital Access Fund, LLC
Consolidated Schedule of Investments
June 30, 2026 (Unaudited)
| Investments - 111.9%⁷ | Sector | Investment Type | Acquisition Date |
Shares | Cost | Fair Value | |||||||||
| Direct Investments - 73.7%¹ʼ² | |||||||||||||||
| Direct Credit - 0.2% | |||||||||||||||
| North America - 0.2% | |||||||||||||||
| Donut Acquisition Co.9,10 ($49,091 principal amount, 8.42% Cash (CME Term SOFR 3M+4.75%, 1.00% Floor), 5/30/2031) |
Consumer Staples | Subordinated debt | 5/30/2025 | $ | 49,091 | $ | 49,586 | ||||||||
| Gula Buyer, Inc.9,10 ($244,500 principal amount, 8.13% Cash (CME Term SOFR 1M+4.50%, 0.75% Floor), 10/25/2031) |
Consumer Discretionary | Subordinated debt | 10/25/2024 | 244,500 | 244,500 | ||||||||||
| PracticeTek Midco, LLC9 ($1,468,068 principal amount, 14% PIK, 8/30/2030) |
Financial Technology | Subordinated debt | 8/30/2023 | 1,468,068 | 1,468,068 | ||||||||||
| Total Direct Credit | 1,761,659 | 1,762,154 | |||||||||||||
| Direct Equity - 73.5% | |||||||||||||||
| Asia - Pacific - 2.9% | |||||||||||||||
| SLP Rainbow Co-Invest, L.P.* | Consumer Staples | Limited partnership interest | 10/1/2022 | 11,141,955 | 11,965,228 | ||||||||||
| SLP Redwood Co-Invest, L.P.* | Communication Services | Limited partnership interest | 10/1/2022 | 8,598,548 | 11,143,732 | ||||||||||
| Total Asia - Pacific | 19,740,503 | 23,108,960 | |||||||||||||
| Europe - 7.8% | |||||||||||||||
| AHP Horsepower Co-Invest L.P.* | Health Care | Limited partnership interest | 12/19/2025 | 5,894 | 5,954,006 | 8,212,063 | |||||||||
| BW CDMO Co-Invest, L.P.* | Health Care | Limited partnership interest | 11/4/2024 | 10,358,553 | 6,277,069 | ||||||||||
| CVC Capital Partners Pachelbel (A) SCSp*3,8 | Education Services | Limited partnership interest | 7/8/2024 | 2,238,381 | 3,376,128 | ||||||||||
| Kirk Beauty Co-Investment Limited Partnership*8 | Consumer Discretionary | Limited partnership interest | 10/1/2022 | 6,888,562 | 2,220,039 | ||||||||||
| LEP CP Co-Invest L.P.*3,8 | Industrials | Limited partnership interest | 3/27/2025 | 6,639,912 | 6,763,607 | ||||||||||
| Mayfair Olympic Holdco Limited*8,9 | Utilities | Ordinary Shares | 10/1/2022 | 1,243,556 | 7,914,290 | 5,264,239 | |||||||||
| Neptune Co-Investment, L.P.*3 | Energy | Limited partnership interest | 10/1/2022 | 9,815,968 | 891,101 | ||||||||||
| SLP Jewel Co-Invest, L.P.* | Consumer Discretionary | Limited partnership interest | 10/1/2022 | 5,883,679 | 7,861,327 | ||||||||||
| SLP Mistral Co-Invest, L.P.* | Financials | Limited partnership interest | 10/1/2022 | 14,200,580 | 18,184,160 | ||||||||||
| SLP Zephyr Investors, L.P.* | Communication Services | Limited partnership interest | 10/1/2022 | 7,836,121 | 3,578,075 | ||||||||||
| Total Europe | 77,730,052 | 62,627,808 | |||||||||||||
See accompanying notes to the Consolidated Schedule of Investments
Constitution Capital Access Fund, LLC
Consolidated Schedule of Investments (Continued)
June 30, 2026 (Unaudited)
| Investments - 111.9%⁷ | Sector | Investment Type | Acquisition Date | Shares | Cost | Fair Value | |||||||||
| Direct Investments (Continued) | |||||||||||||||
| Direct Equity (Continued) | |||||||||||||||
| North America - 62.8% | |||||||||||||||
| ABCL Equity Investors, L.P.* | Professional Services | Limited partnership interest | 8/12/2025 | $ | 5,009,332 | $ | 4,998,981 | ||||||||
| ACP Canopy Co-Invest LLC* | Health Care | Limited liability company interest | 11/1/2022 | 20,082 | 20,081,967 | 26,073,908 | |||||||||
| ACP Ukulele Co-Invest LP | Health Care | Common Units | 3/4/2024 | 25,671 | 3,888,549 | 7,509,790 | |||||||||
| Ares Constellation Private Equity Fund LP*3 | Industrials | Limited partnership interest | 2/25/2026 | 1,630,182 | 2,103,123 | ||||||||||
| Ares EPIC Co-Invest Delaware Feeder, L.P.*3 | Energy | Limited partnership interest | 10/1/2022 | - | 559,801 | ||||||||||
| Ares EPIC Co-Invest II L.P.*3 | Energy | Limited partnership interest | 10/1/2022 | - | 95,500 | ||||||||||
| Avista Healthcare Partners CV II, L.P.3 | Industrials | Limited partnership interest | 7/1/2025 | 2,031,981 | 2,259,318 | ||||||||||
| BP ACE CV, L.P.*3 | Information Technology | Limited partnership interest | 12/12/2025 | 7,655,815 | 10,612,310 | ||||||||||
| Brightwood MOI, LLC*9 | Consumer Discretionary | Limited liability company interest | 1/5/2026 | 5,000,000 | 5,000,000 | ||||||||||
| Carlyle Sabre Coinvestment, L.P.* | Industrials | Limited partnership interest | 10/1/2022 | 4,325,654 | 10,234,216 | ||||||||||
| CC AEC Co-Invest L.P.* | Health Care | Limited partnership interest | 10/1/2022 | 5,948 | 5,957,934 | 3,269,007 | |||||||||
| CCP AMP Holdings, LLC* | Health Care | Limited liability company interest | 11/28/2025 | 10,038,961 | 21,172,033 | ||||||||||
| Centeotl Co-Invest B, L.P.*3 | Consumer Staples | Limited partnership interest | 5/15/2023 | 5,160,290 | 5,015,214 | ||||||||||
| COP Accounting Investment, LLC*9 | Industrials | Class A Units | 10/31/2025 | 5,000,000 | 5,017,316 | 5,000,000 | |||||||||
| COP Exterminators Investment, LLC *9 | Consumer Staples | Limited liability company interest | 7/28/2023 | 8,035,714 | 9,000,000 | 11,640,062 | |||||||||
| Donut Topco LLC*9 | Consumer Staples | Class A Units | 5/30/2025 | 10,000 | 10,000,000 | 10,000,000 | |||||||||
| Ergotron Investments, LLC*9 | Industrials | Common Units | 10/1/2022 | 50,000 | 5,000,000 | 5,280,254 | |||||||||
| Gula Co-Invest II, L.P.*3 | Consumer Discretionary | Common Units | 10/23/2024 | 5,000 | 5,025,000 | 7,068,543 | |||||||||
| Hermod Co-Invest, LP*3 | Consumer Discretionary | Common Units | 10/15/2024 | 5,000,000 | 5,154,248 | 9,514,437 | |||||||||
| Hildred Capital ACP-A, LP*3 | Health Care | Limited partnership interest | 11/12/2025 | 5,849,288 | 8,789,038 | ||||||||||
| Hildred Capital Co-Invest-REBA, LP*3 | Health Care | Limited partnership interest | 1/15/2025 | 14,595,795 | 21,823,325 | ||||||||||
| Iaso Fund, L.P.*3 | Health Care | Limited partnership interest | 12/12/2025 | 9,954,380 | 10,560,845 | ||||||||||
| Ishtar Co-Invest-B LP*3 | Consumer Staples | Limited partnership interest | 11/4/2022 | 5,851,409 | 47,984,000 | ||||||||||
| KLC Fund 0325-CI LP*3 | Health Care | Limited partnership interest | 5/9/2025 | 4,098,537 | 4,000,000 | ||||||||||
| LC Ahab Aggregator, LP* | Consumer Discretionary | Limited partnership interest | 7/31/2024 | 5,000 | 3,104,978 | 9,002,907 | |||||||||
| LC10 Flash Non-US Aggregator, LP | Consumer Discretionary | Class A Units | 2/6/2026 | 5,000 | 4,427,607 | 7,989,768 | |||||||||
| LCG5 Candlelight, L.P.* | Communication Services | Limited partnership interest | 2/24/2025 | 1,000,000 | 10,322,863 | 22,000,278 | |||||||||
| LCMM Revolution Aggregator, L.P.* | Consumer Discretionary | Class A Units | 7/14/2025 | 5,000 | 5,016,787 | 7,934,265 | |||||||||
| LGP Sage CVT Coinvest LP*3 | Industrials | Limited partnership interest | 3/10/2026 | 5,735,415 | 7,189,614 | ||||||||||
| LGP Sage PC Coinvest LP3 | Industrials | Limited partnership interest | 5/1/2025 | 7,745,717 | 11,230,791 | ||||||||||
| LH Equity Investors, L.P.* | Industrials | Limited partnership interest | 9/3/2025 | 9,633,007 | 13,591,792 | ||||||||||
See accompanying notes to the Consolidated Schedule of Investments
Constitution Capital Access Fund, LLC
Consolidated Schedule of Investments (Continued)
June 30, 2026 (Unaudited)
| Investments - 111.9%⁷ | Sector | Investment Type | Acquisition Date | Shares | Cost | Fair Value | |||||||||
| Direct Investments (Continued) | |||||||||||||||
| Direct Equity (Continued) | |||||||||||||||
| North America (Continued) | |||||||||||||||
| MiddleGround Edge Co-Invest Partners, L.P.*9 | Industrials | Limited partnership interest | 6/30/2026 | 7,692,308 | $ | 10,000,000 | $ | 15,221,819 | |||||||
| MyTown Health Partners Parent, LP*3,9 | Health Care | Limited partnership interest | 7/17/2024 | 5,458,864 | 6,075,796 | 7,189,702 | |||||||||
| NBPT Aggregator, LLC*3,9 | Health Care | Preferred Units | 2/28/2025 | 8,000 | 8,023,333 | 10,493,972 | |||||||||
| NE Parent Holdings, LLC*9 | Communication Services | Common Units | 8/29/2025 | 65,313 | 4,441,028 | 6,894,437 | |||||||||
| NE Parent Holdings, LLC*9 | Communication Services | Preferred Units | 8/29/2025 | 5,050 | 3,515,098 | 4,847,039 | |||||||||
| Oshun Co-Invest-B LP*3 | Consumer Staples | Limited partnership interest | 11/4/2022 | 3,208,978 | 2,857,550 | ||||||||||
| PT Co-Invest II, L.P.*3 | Financial Technology | Limited partnership interest | 8/28/2023 | 10,096,741 | 11,729,038 | ||||||||||
| RCP Monte Nido Co-Investment Fund, L.P.* | Health Care | Limited partnership interest | 4/10/2023 | 6,256,226 | 3,693,165 | ||||||||||
| RCP MQ Co-Investment Fund, L.P.* | Health Care | Limited partnership interest | 12/2/2024 | 3,453,460 | 6,595,442 | ||||||||||
| RCP Ocean Co-Investment Fund, L.P.* | Information Technology | Limited partnership interest | 4/23/2025 | 6,171,604 | 6,608,182 | ||||||||||
| s20 SPV VIII, a Series of CGF2021 LLC* | Financials | Limited partnership interest | 9/30/2025 | 10,550,794 | 23,169,567 | ||||||||||
| s20 SPV X, a Series of CGF2021 LLC* | Financials | Limited partnership interest | 10/15/2025 | 5,594,970 | 11,840,000 | ||||||||||
| SLP Blue Co-Invest, L.P. | Information Technology | Limited partnership interest | 10/1/2022 | 8,733,044 | 8,002,032 | ||||||||||
| SLP West Holdings Co-Invest II, L.P.5 | Communication Services | Limited partnership interest | 10/1/2022 | 9,344 | 640,027 | ||||||||||
| Thorium AppDirect Co-Invest, LLC* | Information Technology | Limited liability company interest | 9/30/2024 | 10,000,000 | 10,806,012 | 27,900,908 | |||||||||
| TPG VII Renown Co-Invest II, L.P.* | Consumer Discretionary | Limited partnership interest | 10/1/2022 | 5,098,713 | 37,623 | ||||||||||
| VAL CoInvest, LP*3 | Industrials | Limited partnership interest | 1/6/2026 | 5,049,554 | 7,492,500 | ||||||||||
| VCP Roland Co-Invest Aggregator, L.P.* | Consumer Staples | Limited partnership interest | 10/21/2024 | 5,000 | 5,094,389 | 4,995,474 | |||||||||
| VCP Tech24 Co-Invest Aggregator, L.P.* | Business Services | Limited partnership interest | 5/15/2024 | 5,000 | 5,669,741 | 4,666,139 | |||||||||
| WE Select Fund 1, L.P.*3 | Health Care | Limited partnership interest | 2/5/2025 | 4,561,346 | 5,698,815 | ||||||||||
| WPP Fairway Aggregator B, L.P.*9 | Consumer Staples | Class A Preferred Units | 10/1/2022 | 13,053 | 13,053,292 | 13,061,759 | |||||||||
| WPP Fairway Aggregator B, L.P.*9 | Consumer Staples | Class B Common Units | 10/1/2022 | 13,053 | 87,364 | - | |||||||||
| Total North America | 331,863,839 | 503,138,310 | |||||||||||||
| Total Direct Equity | 429,334,394 | 588,875,078 | |||||||||||||
| Total Direct Investments - 73.7% | 431,096,053 | 590,637,232 | |||||||||||||
See accompanying notes to the Consolidated Schedule of Investments
Constitution Capital Access Fund, LLC
Consolidated Schedule of Investments (Continued)
June 30, 2026 (Unaudited)
| Investments - 111.9%⁷ | Sector | Investment Type | Acquisition Date |
Shares | Cost | Fair Value | |||||||||
| Investment Funds - 36.6%¹ʼ² | |||||||||||||||
| Asia - Pacific - 1.9% | |||||||||||||||
| BPEA Private Equity Fund VI, L.P.23 | Limited partnership interest | 10/1/2022 | $ | 10,242,680 | $ | 1,585,806 | |||||||||
| BPEA Private Equity Fund VII, SCSp3 | Limited partnership interest | 10/1/2022 | 19,009,158 | 13,861,840 | |||||||||||
| Total Asia - Pacific | 29,251,838 | 15,447,646 | |||||||||||||
| Europe - 6.8% | |||||||||||||||
| CVC Capital Partners VI (D) S.L.P.3,8 | Limited partnership interest | 10/1/2022 | 13,589,985 | 7,085,877 | |||||||||||
| CVC Capital Partners VII (A) L.P.3,8 | Limited partnership interest | 10/1/2022 | 16,223,840 | 14,232,477 | |||||||||||
| EQT IX (No.1) EUR SCSp3,8 | Limited partnership interest | 10/1/2022 | 12,136,291 | 13,316,312 | |||||||||||
| EQT VII (No.1) Limited Partnership*3,8 | Limited partnership interest | 10/1/2022 | 7,672,322 | 3,882,413 | |||||||||||
| EQT VIII (No.1) SCSp3,8 | Limited partnership interest | 10/1/2022 | 17,050,800 | 7,582,524 | |||||||||||
| Sixth Cinven Fund (No. 2) Limited Partnership3,8 | Limited partnership interest | 10/1/2022 | 17,560,974 | 8,494,259 | |||||||||||
| Total Europe | 84,234,212 | 54,593,862 | |||||||||||||
| North America - 27.9% | |||||||||||||||
| Ares Corporate Opportunities Fund V, L.P.*3 | Limited partnership interest | 10/1/2022 | 12,697,020 | 8,630,918 | |||||||||||
| Ares Corporate Opportunities Fund VI Parallel (TE), L.P.3 | Limited partnership interest | 10/1/2022 | 19,466,380 | 28,335,474 | |||||||||||
| Ares Energy Opportunities Fund B, L.P.3 | Limited partnership interest | 10/1/2022 | 3,175,675 | 1,925,433 | |||||||||||
| Avista Healthcare Partners (Offshore) II, L.P.3 | Limited partnership interest | 3/31/2025 | 9,715,083 | 11,738,294 | |||||||||||
| Bansk Fund I-B, L.P.*3 | Limited partnership interest | 9/13/2023 | 2,497,899 | 5,252,547 | |||||||||||
| Bansk Fund II-B, L.P.*3 | Limited partnership interest | 1/30/2026 | 2,559,619 | 2,588,005 | |||||||||||
| Carlyle International Energy Partners II S.C.Sp.3 | Limited partnership interest | 10/1/2022 | 13,222,073 | 12,388,190 | |||||||||||
| Carlyle Partners VI, L.P.3,4 | Limited partnership interest | 10/1/2022 | 3,835,031 | 1,052,409 | |||||||||||
| Carlyle Partners VII, L.P.3 | Limited partnership interest | 10/1/2022 | 7,604,385 | 7,308,191 | |||||||||||
| Catterton Partners VII, L.P.*3 | Limited partnership interest | 10/1/2022 | 17,152,531 | 9,743,379 | |||||||||||
| Gridiron Capital (Parallel) Fund V, L.P.*3 | Limited partnership interest | 11/27/2023 | 4,459,597 | 5,271,921 | |||||||||||
| Insignia Capital Partners, L.P.3,4 | Limited partnership interest | 10/1/2022 | 28,787,806 | 8,117,791 | |||||||||||
| Investcorp Strategic Capital Partners II-B, L.P.*3 | Limited partnership interest | 3/27/2026 | 1,320,376 | 1,252,759 | |||||||||||
| L Catterton Growth VI, L.P.*3 | Limited partnership interest | 1/30/2026 | 36,501 | 248,835 | |||||||||||
| Lightyear Fund III, L.P.4 | Limited partnership interest | 10/1/2022 | - | 21,565 | |||||||||||
| Revelstoke Capital Partners Fund III, L.P.3 | Limited partnership interest | 8/22/2023 | 4,198,483 | 5,125,503 | |||||||||||
| Riverstone Global Energy and Power Fund VI, L.P.3 | Limited partnership interest | 10/1/2022 | 3,582,032 | 924,362 | |||||||||||
| Riverstone Non-ECI Partners, L.P.3 | Limited partnership interest | 10/1/2022 | 8,494,738 | 59,609 | |||||||||||
| Sage Equity Investors Side, L.P.*3 | Limited partnership interest | 2/10/2026 | 1,113,471 | 1,641,466 | |||||||||||
| Silver Lake Partners IV, L.P.3,4 | Limited partnership interest | 10/1/2022 | 12,647,292 | 14,633,782 | |||||||||||
| Silver Lake Partners V, L.P.3,4 | Limited partnership interest | 10/1/2022 | 18,141,133 | 18,712,037 | |||||||||||
See accompanying notes to the Consolidated Schedule of Investments
Constitution Capital Access Fund, LLC
Consolidated Schedule of Investments (Continued)
June 30, 2026 (Unaudited)
| Investments - 111.9%⁷ | Sector | Investment Type | Acquisition Date |
Shares | Cost | Fair Value | |||||||||
| Investment Funds (Continued) | |||||||||||||||
| North America (Continued) | |||||||||||||||
| SK Capital Partners III, L.P.*3 | Limited partnership interest | 10/1/2022 | $ | 20,659,748 | $ | 4,113,766 | |||||||||
| SL SPV-2, L.P. | Limited partnership interest | 10/1/2022 | 5,097,745 | 13,671,531 | |||||||||||
| SunTx Capital Partners II, L.P.* | Limited partnership interest | 10/1/2022 | 6,048,777 | 26,146,840 | |||||||||||
| TPG HealthCare Partners, L.P.*3 | Limited partnership interest | 10/1/2022 | 5,522,762 | 6,220,851 | |||||||||||
| TPG Partners VI, L.P.*3 | Limited partnership interest | 10/1/2022 | 2,668,398 | 643,765 | |||||||||||
| TPG Partners VIII, L.P.3 | Limited partnership interest | 10/1/2022 | 19,043,555 | 18,917,672 | |||||||||||
| Webster Equity Partners VI, L.P.*3 | Limited partnership interest | 2/3/2026 | 1,508,486 | 1,443,578 | |||||||||||
| WestView Capital Partners III, L.P.*3 | Limited partnership interest | 10/1/2022 | 8,420,990 | 1,547,818 | |||||||||||
| Wind Point Partners VII-B, L.P.*3 | Limited partnership interest | 10/1/2022 | 1,762,977 | 26,780 | |||||||||||
| Wind Point Partners X-B, L.P.*3 | Limited partnership interest | 4/5/2024 | 4,585,565 | 5,607,429 | |||||||||||
| Total North America | 250,026,128 | 223,312,500 | |||||||||||||
| Total Investment Funds - 36.6% | 363,512,178 | 293,354,008 | |||||||||||||
| Short-Term Investments - 1.6% | |||||||||||||||
| North America - 1.6% | |||||||||||||||
| Fidelity Institutional Government Portfolio - Class I, 3.53%6 | 13,012,587 | 13,012,587 | 13,012,587 | ||||||||||||
| Total Short-Term Investments - 1.6% | 13,012,587 | 13,012,587 | |||||||||||||
| Total Investments - 111.9% | 807,620,818 | 897,003,827 | |||||||||||||
| Net Other Assets (Liabilities) - (11.9%) | (95,228,724) | ||||||||||||||
| Total Net Assets - 100.0% | $ | 801,775,103 | |||||||||||||
Legend
| SOFR | - Secured Overnight Financing Rate |
| CME Term SOFR 1M - Chicago Mercantile Exchange forward looking measure of SOFR for one month: 3.65%, as of June, 2026. Actual reference rates may vary based on the reset date of the security. |
| CME Term SOFR 3M - Chicago Mercantile Exchange forward looking measure of SOFR for three months: 3.73%, as of June 30, 2026. Actual reference rates may vary based on the reset date of the security. |
| * | Investment is non-income producing. |
| 1 | Direct Investments and Investment Funds are generally issued in private placement transactions and as such are generally restricted as to resale. Each investment may have been acquired on various dates and for different amounts. The acquisition date is shown in the Consolidated Schedule of Investments. Total fair value of restricted investments as of June 30, 2026 was $883,991,240, or 110.3% of net assets. Total cost of restricted investments as of June 30, 2026 was $794,608,231. |
| 2 | Direct Investments and Investment Funds do not allow redemptions or withdrawals except at discretion of their general partner, manager, or adviser. |
| 3 | Investment has been committed to but has not been fully funded by the Fund. |
| 4 | All or a portion of this security is held through a consolidated Subsidiary, CC PMF Splitter Partnership. |
| 5 | All or a portion of this security is held through a consolidated Subsidiary, CC PMF Blocker, LLC. |
| 6 | The rate is the annualized seven-day yield as of June 30, 2026. |
| 7 | Investments are held through CC PMF Holdings, LLC, a consolidated Subsidiary, unless otherwise denoted. |
| 8 | Foreign security denominated in U.S. Dollars. |
| 9 | The fair value of the investment was determined using significant unobservable inputs. |
| 10 | Variable rate security. Rate shown is the rate in effect as of June 30, 2026. |
See accompanying notes to the Consolidated Schedule of Investments
Constitution Capital Access Fund, LLC
Notes To Consolidated Schedule of Investments
June 30, 2026 (Unaudited)
Note 1 - Valuation of Investments
The Fund invests, under normal circumstances, in a broad portfolio of private assets and values them at fair value in accordance with the provisions of ASC Topic 820, Fair Value Measurements and Disclosures (“ASC 820”). The Fund’s investments include a broad portfolio of high-quality investments in private assets that the Adviser believes provide attractive risk-adjusted return potential. Private asset investments include Direct Investments (except for publicly listed private equity investments), Secondary Investments, and Primary Investments, each as defined below (collectively, “Private Assets”). Private Assets include (i) direct investments in the equity or debt of operating companies and investments in co-investment vehicles managed or sponsored by a third-party investment manager (“Sponsor”) to access positions in the equity or debt of a single operating company (“Direct Equity Investments” or “Direct Credit Investments,” respectively, and together, “Direct Investments”); (ii) secondary purchases (i.e. purchases of existing interests that are acquired on the private secondary market) (“Secondary Investments”) of closed-end private funds (“Portfolio Funds”) managed by Sponsors; and (iii) primary investments in Portfolio Funds (i.e. commitments to new private equity or other private funds, which are sourced and diligenced by the Adviser (“Primary Investments”). The Fund’s investments may also include (iv) direct or secondary purchases of liquid credit instruments; (v) other liquid investments, such as investments in publicly listed companies that pursue the business of private equity investing, including private equity investments that are publicly traded, listed funds of funds, alternative asset managers, holding companies, investment trusts, closed-end funds, financial institutions and other vehicles whose primary purpose is to invest in privately held companies (“Other Liquid Investments”); and (vi) short-term investments, which generally are cash equivalents that represent investments in high quality money market instruments and/or money market mutual funds (together, “Short-term Investments”). The investments covered by romanettes (iv) through (vi) are not Private Assets.
The Adviser has been designated by the Board as the valuation designee for the Fund pursuant to Rule 2a-5 of the Investment Company Act (“Rule 2a-5”) to perform fair value determinations and has approved valuation procedures for the Fund. Rule 2a-5 establishes requirements for determining fair value in good faith for purposes of the Investment Company Act, defines when market quotations are “readily available” for purposes of the Investment Company Act and the threshold for determining whether a fund must fair value a security.
Where available, the Fund uses the net asset value (“NAV”) reported by Sponsors and Investment Fund Managers as a practical expedient in determining their fair values as of a valuation date for the Fund, in accordance with ASC 820. If the most recent NAV is reported as of a date which does not align with the valuation date for the Fund, the Adviser assesses whether an adjustment to the most recently reported NAV is justified in accordance with the Fund’s valuation procedures. In making this assessment, the Adviser considers, among other things, information provided by the Sponsors and Investment Fund Managers, including quarterly unaudited financial statements and cash flow activity observed during the period between the most recently reported NAV date and the valuation date for the Fund. The Adviser will also review the appropriateness of the adjustment to the most recently reported NAV based on any new information or changes in assumptions regarding the security, reliable public information, actual trade prices or other information that becomes available subsequent to the most recently reported NAV.
If an investment does not meet the qualifications of an investment company under ASC 946, the Adviser may make a fair value determination by utilizing information provided by the Sponsor or Investment Fund Manager, including quarterly unaudited financial statements, financial forecasts, and cash flow activity observed during the valuation period. The Adviser may also utilize the cost of the investment, or income and market-based valuation techniques acceptable under ASC 820, which may incorporate unobservable inputs. These techniques may include references to market multiples, valuations for comparable companies, public market or private transactions, subsequent developments concerning the companies to which the securities relate, results of operations, financial condition, cash flows, and projections of such companies provided to the Adviser and such other factors as the Adviser may deem relevant. Depending on the circumstances, company multiples will not always be comparable due to the size of the related companies or associated transactions being used as comparable data in valuation.
Constitution Capital Access Fund, LLC
Notes To Consolidated Schedule of Investments (Continued)
June 30, 2026 (Unaudited)
As part of its valuation process, the Adviser also performs backtesting of its fair value estimates against information that is subsequently received from Sponsors and Investment Fund Managers, where available. The Adviser has established an internal valuation committee consisting of senior members of the organization to review and approve valuations related to the Direct Investments and Investment Funds as of each valuation date.
The Board oversees the Adviser in its role as valuation designee and receives quarterly reports from the Adviser regarding the valuation of the Direct Investments and Investment Funds, including information regarding fair value determinations, valuation methodologies, and any changes to valuation policies or procedures.
For investments that are publicly traded and have market quotations readily available on one or more of the U.S. national securities exchanges, the Nasdaq Stock Market or any foreign stock exchange, valuations will be based on their respective market price and may be further adjusted for potential restrictions on the transfer or sale of such securities.
Note 2 – Fair Value Measurements
ASC 820 defines fair value as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date (i.e., the exit price), or in the absence of a principal market, the most advantageous market for the asset, and establishes a fair value hierarchy for inputs used in measuring fair value that maximizes the use of observable inputs and minimizes the use of unobservable inputs by requiring that the most observable inputs be used when available. Observable inputs are those that market participants would use in pricing the asset or liability based on market data obtained from sources independent of the Adviser. Unobservable inputs reflect the Adviser’s assumption about the inputs market participants would use in pricing the asset or liability developed based on the best information available in the circumstances. The fair value hierarchy is categorized into three levels based on the inputs as follows:
Level 1 – Unadjusted quoted prices in active markets for identical assets or liabilities that the reporting entity has the ability to access at the measurement date. The types of financial instruments included in Level 1 are listed unrestricted securities, equities and listed derivatives, if any, listed in active markets.
Level 2 – Inputs other than quoted prices within Level 1 that are observable for the asset or liability, either directly or indirectly in active markets as of the reporting date, and fair value that is determined using models or other valuation methodologies. Financial instruments in this category generally include corporate bonds and loans, less liquid and restricted securities listed in active markets, securities traded in other than active markets, government and agency securities, over-the-counter derivatives where fair value is based on observable inputs and interests in Private Assets whose fair value is predominantly attributable to investments in Level 1 type securities. A significant adjustment to a Level 2 input could result in the Level 2 measurement becoming a Level 3 measurement.
Level 3 – Inputs that are unobservable for the asset or liability and that include situations where there is little, if any, market activity for the asset or liability. The inputs into the determination of fair value are based upon the best information in the circumstances and may require significant management judgment or estimation. Financial instruments in this category generally include equity and debt positions in private companies, and non-redeemable investments in alternative investment funds, non-investment grade residual interests in securitizations, collateralized loan obligations, and certain over-the-counter derivatives, if any, where the fair value is based on unobservable inputs.
ASC 820 also permits a reporting entity to measure the fair value of an asset that does not have a readily determinable fair value based on the reported NAV per share, or its equivalent, as a practical expedient for its fair value. Accordingly, the Fund may utilize the NAV per share as reported by certain Sponsors and Investment Fund Managers as of a valuation date as a practical expedient for its fair value. If the NAV reported by certain Sponsors and Investment Fund Managers is not as of the same date as the valuation date, the Fund is permitted under ASC 820 to estimate the fair value of those Private Assets by adjusting the most recently reported NAV as a practical expedient for fair value.
Constitution Capital Access Fund, LLC
Notes To Consolidated Schedule of Investments (Continued)
June 30, 2026 (Unaudited)
The Fund’s investments that are measured at fair value using NAV per share (or its equivalent) as a practical expedient are generally not redeemable during the life of each Direct Investment and Investment Fund. These investments may be subject to lock-up provisions, investment periods, and other restrictions on transfer, and the Fund may not be able to sell such interests in Direct Investments and Investment Funds in secondary transactions at amounts approximating NAV.
Due to the inherent uncertainty of estimates, fair value determinations based on estimates may materially differ from the values that would have been used had a ready market for the securities existed.
The inputs or methodology used for valuing securities are not an indication of the risk associated with investing in those securities.
The following table is a summary of information about the levels within the fair value hierarchy at which the Fund’s investments are measured as of June 30, 2026:
| Level 1 | Level 2 | Level 3 | NAV
as a Practical Expedient(1) | Total | ||||||||||||||||
| Investments | ||||||||||||||||||||
| Direct Investments | $ | — | $ | 2,220,039 | $ | 101,655,437 | $ | 486,761,756 | $ | 590,637,232 | ||||||||||
| Investment Funds | — | — | — | 293,354,008 | 293,354,008 | |||||||||||||||
| Short-Term Investments | 13,012,587 | — | — | — | 13,012,587 | |||||||||||||||
| Total Investments | $ | 13,012,587 | $ | 2,220,039 | $ | 101,655,437 | $ | 780,115,764 | $ | 897,003,827 | ||||||||||
| (1) | Direct Investments and Investment Funds that are measured at fair value using NAV (or its equivalent) as a practical expedient are not required to be categorized in the fair value hierarchy. The fair values presented in this table are intended to permit reconciliation of the fair value hierarchy to the amounts presented in the Consolidated Schedule of Investments. |